Recent News
Widow of Ovarian Cancer Victim Claims Talcum Powder Can Prove Deadly
A California man has filed a wrongful death lawsuit against Johnson & Johnson, alleging that his wife’s long-term use of its Baby Powder and Shower-to-Shower talc products caused her to develop ovarian cancer that eventually proved fatal. The talcum powder … Continue reading
Invokana Review Launched in Europe Over Lower-Limb Amputations
Drug safety regulators are trying to determine if Invokana (canagliflozin) might be linked to lower-limb amputations. In a statement issued on April 15th, the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) said it has requested more information from … Continue reading
More Nexium Worries, as Another Study Links PPIs to Kidney Failure
Yet another study has suggested that the long-term use of Nexium and other proton pump inhibitors could potentially harm the kidneys. The research, which appeared this month in the Journal of the American Society of Nephrology, suggested that patients who … Continue reading
Bair Hugger Lawsuit Filings Continue to Climb
Lawsuits filed over the 3M Bair Hugger forced air warming blanket continue to mount in the centralized proceeding underway in Minnesota. According to an update issued by the U.S. Judicial Panel on Multidistrict Litigation on April 15th, there are currently … Continue reading
Study Links Fluoroquinolone Antibiotics to Serious Eye Injury
Patients who use Levaquin and other fluoroquinolone antibiotics should be on alert for the symptoms of a serious eye injury called retinal detachment. Just last month, a group of French researchers reported findings that suggested current use of a fluoroquinolone … Continue reading
New Actos Study Confirms Bladder Cancer Risk
Yet another study has tied Actos to the development of bladder cancer. This time, Canadian researches found that use of the Type 2 diabetes drug might increase a patient’s risk for the disease by as much as 63%. Actos (pioglitazone) … Continue reading
Onglyza Heart Failure Risk Prompts New FDA Warning
Patients who use Onglyza (saxagliptin) should be on guard for heart failure symptoms, according to a new warning from U.S. drug safety regulators. Labels for Onglyza and number of other Type 2 diabetes drugs are now being updated to provide … Continue reading
Courts Gearing Up for More Talc Powder Ovarian Cancer Trials
The litigation involving Johnson & Johnson’s talc-based products is expected to heat up over the coming year. According to Harris Martin, the next 12 months could see several jury trials convened over the alleged link between the company’s talcum powders … Continue reading
Taxotere Lawsuit Plaintiff Claims Drug Maker Downplayed Permanent Hair Loss Risk
A California woman has filed a new lawsuit against Sanofi-Aventis, claiming that the company downplayed the link between Taxotere and permanent hair loss. The complaint, which is now pending in the U.S. District Court, Northern District of California, asserts that … Continue reading
Pennsylvania Mom Blames Zofran for Son’s Cleft Palate
A Pennsylvania mom claims that her son’s first few days of life were a nightmare, all because of a cleft palate he allegedly developed due to Zofran. “Struggling, sitting up, wondering and crying every night if your baby is going … Continue reading
Follow Us
